# UNIVERSITY OF ALABAMA AT BIRMINGHAM: Targeting MBD2 for medulloblastoma therapy

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF ALABAMA AT BIRMINGHAM |
| Location | BIRMINGHAM, AL |
| Project | Targeting MBD2 for medulloblastoma therapy |
| Project number | 5R01NS144449-02 |
| Mechanism | R01 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $564,200 |
| Awarded | 2026-09-08 |
| Project period | 2025-09-09 to 2030-08-31 |
| UEI | YND4PLMC9AN7 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11412727). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.